AMPLYCELL
Amplycell is a biotech service company of which mission is to optimize recombinant protein.
AMPLYCELL
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Liège, Liege, Belgium
Country:
Belgium
Website Url:
http://www.amplycell.com
Total Employee:
1+
Status:
Active
Contact:
+32 42 66 94 93
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
ALMIRALL HERMAL
Almirall is a global, research-focused biopharmaceutical company to provide medical solutions.
NADAG AG
A drug discovery company with clinical and preclinical projects.
Selexel
SeleXel is a biotechnology company whose mission is to develop efficient therapeutic solutions.
Xcellsyz
Xcellsyz is a biotechnology company, focusses on the discovery of new drugs.
Official Site Inspections
http://www.amplycell.com
- Host name: ec2-18-119-154-66.us-east-2.compute.amazonaws.com
- IP address: 18.119.154.66
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amplycell"
Amplycell - Crunchbase Company Profile & Funding
Amplycell is a biotech service company of which mission is to optimize recombinant protein. Liège, Liege, Belgium; 1-10; Private; www.amplycell.com ; 2,521,831See details»
Amplycell Company Profile 2024: Valuation, Funding & Investors
Amplycell General Information Description. Developer of a technology intended to facilitate and optimize monoclonal antibody productions. The company's technology offers physical …See details»
AmplyCell - Products, Competitors, Financials, Employees, …
AmplyCell is a spin-off emerging from Wallonia's Haute Ecoles. Since its inception, the company has been working on international projects in the Biotech Pharma and IVD industry for large …See details»
AmplyCell SA - Drug pipelines, Patents, Clinical trials - Synapse
Oct 14, 2024 Explore AmplyCell SA with its drug pipeline, therapeutic area, technology platform, .See details»
AmplyCell - Overview, News & Similar companies | ZoomInfo.com
AmplyCell has been created after 7 years R&D developments by the Haute Ecole de la Province de Liège (Engineer school) and CECOTEPE Research Center. Created in 2014, April, …See details»
Amplycell - Company Profile - Tracxn
Amplycell - Develops cell culture reagent. Founded by Geoffrey Holsbeek in the year 2007. Amplycell has 872 competitors.See details»
Amplycell - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Amplycell . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 4. About. Amplycell is actively using …See details»
AmplyCell S.A. - life-sciences-europe.com
Apr 1, 2014 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Amplycell - Crunchbase
Amplycell is a biotech service company of which mission is to optimize recombinant protein.See details»
AmplyCell – optimizing monoclonal antibody production
AmplyCell is a spin-off emerging from « Centre de Coopération Technique et Pédagogique » (CECOTEPE), a research center in Liège (Belgium). Amply Cell was founded by experts in …See details»
New spin-off AmplyCell to boost antibody production - BioVox
Jan 25, 2016 AmplyCell is the first spin-off from the College of the Province of Liege. This service company has developed an innovative advanced technology, based on “cellular …See details»
Amplycell - Facebook
Amplycell, Liège. 138 likes. Amplycell has create the Cell Fitness... So boost your cell lines!See details»
AmplyCell, première spin-off issue de la Haute École de la ... - CCI …
Jan 14, 2016 AmplyCell est la première spin-off issue de la Haute École de la Province de Liège. Cette société de service a mis au point une technologie de pointe innovante, reposant sur le « …See details»
Horizon Discovery partners with Amplycell SA for bioproduction …
Horizon Discovery Group plc, the world leader in the application of gene editing technologies, including the provision of bioproduction cell lines, today announced it has entered into a …See details»
Horizon to Evaluate AmplyCell BOOST Platform to Improve Cell …
Mar 8, 2017 AmplyCell’s Cell Fitness Technologies, including BOOST, involve a four-stage process that is designed to activate cell line metabolism to improve cell line stability and …See details»
Horizon Discovery enters into R&D and licensing partnership | The ...
Mar 7, 2017 Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies, including the provision of bioproduction cell lines, …See details»
Amplycell - Manufacturing Chemist
Hybrid interferons: developing a novel drug class With many hurdles to overcome, establishing a new drug candidate is a long process — particularly if you are a smaller biotech company with …See details»
Horizon Discovery enters into R&D and licensing ... - SynBioBeta
Cambridge, UK and Liege, BE, 8 March 2017-Horizon Discovery Group plc (LSE: HZD) ("Horizon"), the world leader in the application of gene editing technologies, including the …See details»
Horizon Discovery partners with Amplycell on cell line optimisation
The collaboration is to evaluate the impact of AmplyCell’s BOOST cell line optimisation technology on Horizon’s parental GS (glutamine synthetase) null CHO K1 cell line. …See details»
Horizon inks research pact with amplycell for bioproduction cell …
Horizon Discovery Group, the world leader in the application of gene editing technologies, including the provision of bioproduction cell lines, has entered into a research and …See details»